Exercise in Methamphetamine Use Disorder Upregulation and Neural Function

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

113

Participants

Timeline

Start Date

June 26, 2019

Primary Completion Date

August 30, 2023

Study Completion Date

August 30, 2023

Conditions
Methamphetamine Abuse
Interventions
BEHAVIORAL

EX

An individualized aerobic and resistance-exercise program will be developed for each participant on the basis of a maximal incremental exercise test and strength assessments performed at baseline. This test will measure aerobic capacity (VO2 max) and the metabolic or lactate threshold (VO2θ) (i.e., the level of O2 uptake that defines one's ability to perform prolonged work), using indirect calorimetry with an automated metabolic-measurement system. The intervention will comprise 24 sessions over 8 wk (3x/wk), supervised by a credentialed exercise specialist. Each session will consist of a 5-min warm-up, 30-40 min of aerobic activity on a treadmill, 15-20 min of resistance training, and a 5-min cool-down.

BEHAVIORAL

CON

Participants attend 50-min sessions 3x/wk matched to EX for staff contact. A counselor will facilitate integrative group discussions, and will conduct a multimedia program addressing various health, wellness and lifestyle topics, such as nutrition, dental care, stress relief, sleep hygiene, relationships, immunizations, health screening, smoking, environmental health, and time management.

Trial Locations (1)

90006

University of California Los Angeles, Los Angeles

All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

University of California, Los Angeles

OTHER

NCT03709667 - Exercise in Methamphetamine Use Disorder Upregulation and Neural Function | Biotech Hunter | Biotech Hunter